Par Pharmaceutical Names Michael Tropiano as CFO
Par Pharmaceutical, US-based specialty pharmaceutical company, has announced the resignation of Lawrence Kenyon, executive vice president and chief financial officer (CFO), effective 30 June 2010, to pursue other opportunities. Michael Tropiano, Par’s treasurer, will replace Kenyon.
Tropiano joined Par in August 2005 as vice president and treasurer. During his tenure, he has led several initiatives including building a financial, planning and analysis team, developing the company’s three-year strategic plan, as well the early redemption of the company’s convertible debentures. Prior to joining Par, Tropiano served as vice president and corporate treasurers of MedPointe Pharmaceuticals from 2001-2005 and assistant treasurer at Carter-Wallace from 1984-2001. He began his career as a treasury analyst at Orange and Rockland Utilities. Tropiano received his MBA in Finance from Fordham University and a BA in Economics from Siena College. He is also a chartered financial consultant (CFC).